HRC Ledger

Lisinopril Tablets (VA-27-00004937)

NewCloses September 24, 2026clinicalOpportunity
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0032 for an unrestricted procurement for Lisinopril Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted item. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line items 3, 4, 7, 8, 11, 12, 14, 18, 19, and 31 for 45 and 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0032 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 3, 2026 with a tentative closing date of September 24, 2026 The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to Youlanda.Duggar@va.gov. Please see the Excel spreadsheet for estimated annual quantities.
Build pursuit package

Key dates

Response due

September 24, 2026

Posted
August 17, 2026

Details

Buyer
Nac Pharmaceuticals (36E797)
Agency
Nac Pharmaceuticals (36E797)
Buyer type
Federal
Jurisdiction
the United States (US)
Category
Clinical
Value
Set-aside
NAICS
325412
PSC
6505
Source
sam.gov

Organization

Source: Provider universe

Not matched to a provider record yet.

Buying history

Source: Solicitation records
  • Records10 total
  • Opportunities / awards6 / 0
  • Value range$1,932,252 – $436,529,696
  • ActiveJune 10, 2026 – August 17, 2026

What they buy

  • Clinical (10)

Financial highlights

Source: IRS Form 990

No 990 filing on record.

Who holds their work today

Source: Solicitation records · awards

No awards on record for this buyer.

What they're trying to solve

Source: AI-generated

No brief written for this buyer yet.

Also open from this buyer

Source: Solicitation records

Ways to meet this buyer

Source: Solicitation records · event notices

Upcoming

No upcoming events on record.

View source document →

Source link on sam.gov.

← Back to all contracts